Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 3,890.00
-130.00 (-3.23%)
Nov 2, 2026, 3:30 PM KST
| Market Cap | 46.75B -69.2% |
| Revenue (ttm) | 26.07B +82.0% |
| Net Income | -91.50B |
| EPS | -1,522.60 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 125,802 |
| Open | 3,975.00 |
| Previous Close | 4,020.00 |
| Day's Range | 3,690.00 - 3,980.00 |
| 52-Week Range | 3,690.00 - 14,120.00 |
| Beta | 0.53 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |